Literature DB >> 23990514

Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: analysis from DPV database.

Susanne Bechtold1, Astrid Blaschek, Klemens Raile, Axel Dost, Clemens Freiberg, Meik Askenas, Elke Fröhlich-Reiterer, Esther Molz, Reinhard W Holl.   

Abstract

OBJECTIVE Type 1 diabetes and multiple sclerosis (MS) are typical autoimmune diseases in children and young adults. We assessed the co-occurrence of type 1 diabetes and MS by estimating the relative risk (RR) for MS in a pediatric and adolescent diabetic population and looked for possible influencing factors. RESEARCH DESIGN AND METHODS Within the Diabetes Patienten Verlaufsdokumentation (DPV)-Wiss Project, from January 1995 to October 2012, data from 56,653 patients with type 1 diabetes were collected in 248 centers in Germany and Austria. Published data on German and Mid-European MS prevalence were taken for comparison. Multivariable regression analysis was used to identify confounders for co-occurrence of type 1 diabetes and MS. RESULTS The RR for MS in patients with type 1 diabetes was estimated at 3.35-4.79 (95% CI 1.56-7.21 and 2.01-11.39, respectively). Immigration status in all patients (P < 0.05) and the presence of thyroid antibodies in male patients only (P = 0.05) were identified as influencing factors on MS incidence within the DPV database. The month-of-birth pattern revealed that risk was higher during the spring and summer months in the population with type 1 diabetes and MS in comparison with the population with type 1 diabetes. CONCLUSIONS The present cohort study demonstrates a higher risk of co-occurrence of MS in a pediatric and adolescent diabetic population. Immigration status and thyroid antibodies in male patients were independent risk indicators for the incidental rate of MS. Diabetic patients born during spring and summer had a higher risk for the development of MS. We suggest that environmental factors modulate the individual's risk for the co-occurrence of both diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23990514     DOI: 10.2337/dc13-1414

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

Review 1.  The NOD Mouse Beyond Autoimmune Diabetes.

Authors:  Anne-Marie Aubin; Félix Lombard-Vadnais; Roxanne Collin; Holly A Aliesky; Sandra M McLachlan; Sylvie Lesage
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 2.  Multiple Sclerosis and Autoimmunity: A Veiled Relationship.

Authors:  Zineb Barkhane; Jalal Elmadi; Lakshmi Satish Kumar; Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy
Journal:  Cureus       Date:  2022-04-19

3.  Identification of common key genes and pathways between type 1 diabetes and multiple sclerosis using transcriptome and interactome analysis.

Authors:  Nahid Safari-Alighiarloo; Mohammad Taghizadeh; Seyyed Mohammad Tabatabaei; Saeed Namaki; Mostafa Rezaei-Tavirani
Journal:  Endocrine       Date:  2020-01-07       Impact factor: 3.633

4.  Similarities and differences between multiple sclerosis and type 1 diabetes.

Authors:  Valeria Pozzilli; Eleonora Agata Grasso; Valentina Tomassini
Journal:  Diabetes Metab Res Rev       Date:  2021-10-22       Impact factor: 8.128

5.  Rewiring of Glucose and Lipid Metabolism Induced by G Protein-Coupled Receptor 17 Silencing Enables the Transition of Oligodendrocyte Progenitors to Myelinating Cells.

Authors:  Davide Marangon; Matteo Audano; Silvia Pedretti; Marta Fumagalli; Nico Mitro; Davide Lecca; Donatella Caruso; Maria P Abbracchio
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666

6.  Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes.

Authors:  Hildegard Jasser-Nitsche; Susanne Bechtold-Dalla Pozza; Elisabeth Binder; Esther Bollow; Bettina Heidtmann; Young Hee Lee-Barkley; Klemens Raile; Gideon de Sousa; Ursula Schramm; Reinhard W Holl
Journal:  Acta Paediatr       Date:  2020-11-18       Impact factor: 2.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.